Spinal Muscular Atrophy Market
Spinal Muscular Atrophy Market Size, Share & Trends Analysis Report
Spinal Muscular Atrophy Market Size, Share, Statistics & Trends Analysis Report By Type (Type I, Type II, Type III, Type IV), By Treatment (Gene Therapy, Disease-modifying drugs), By Age Group (Infant, Adult), By Route of Administration (Oral, Injectables), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Based On Region, And Segment Forecasts, 2024 – 2030
Published
Report ID : BMRC 2855
Number of pages : 300
Published Date : Feb 2024
Category : Pharmaceutical
Delivery Timeline : 48 hrs
Market Segmentation
By Type:
- Type I
- Type II
- Type III
- Type IV
By Treatment:
- Gene Therapy
- Disease-modifying drugs
By Age Group:
- Infant
- Adult
By Route of Administration:
- Oral
- Injectables
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Key Players
- Astellas Pharma Inc.
- Catalyst Pharmaceuticals, Inc.
- Cure SMA
- CYTOKINETICS
- AstraZeneca
- Novartis AG
- Hoffmann-La Roche Ltd
- Biogen
- Ionis Pharmaceuticals
- Regeneron Pharmaceuticals Inc.
- Pfizer Inc.
- Abbott
SUMMARY
Segments
Market Segmentation
By Type:
- Type I
- Type II
- Type III
- Type IV
By Treatment:
- Gene Therapy
- Disease-modifying drugs
By Age Group:
- Infant
- Adult
By Route of Administration:
- Oral
- Injectables
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
Key Players
- Astellas Pharma Inc.
- Catalyst Pharmaceuticals, Inc.
- Cure SMA
- CYTOKINETICS
- AstraZeneca
- Novartis AG
- Hoffmann-La Roche Ltd
- Biogen
- Ionis Pharmaceuticals
- Regeneron Pharmaceuticals Inc.
- Pfizer Inc.
- Abbott
